AIG Digestive Disease Research

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)3 trials
• Colorectal cancer1 trial
• Type 2 diabetes1 trial
• Ulcerative colitis1 trial

Phase

• Phase 24 trials
• Phase 32 trials

Status

• Completed4 trials
• Active, not recruiting3 trials

Lead sponsor

• Novo Nordisk A/S2 trials
• Abivax S.A.1 trial
• Boehringer Ingelheim1 trial
• Guardant Health, Inc.1 trial
• Inventiva Pharma1 trial
• and 1 more

Running trials

• Active, not recruiting

  ABTECT - Maintenance

  NCT05535946· Phase 3· Abivax S.A.· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

  NCT04136002· Guardant Health, Inc.· Source

Closed trials

• Completed

  Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH

  NCT06054815· Phase 2· NeuroBo Pharmaceuticals Inc.· Source

• Completed

  Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

  NCT05232071· Phase 2· Inventiva Pharma· Source

• Completed

  Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT05016882· Phase 2· Novo Nordisk A/S· Source

• Completed

  A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

  NCT04771273· Phase 2· Boehringer Ingelheim· Source